January 30, 2017

Risk Management Seminar for Applying ISO14971 and IEC62304

IndiaProduction

IndiaProduction

Recommended Reports

Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

KOL Perspectives: Implementation of the treat-to-target approach in IBD

Ubiquitin Carboxyl Terminal Hydrolase 14 (Deubiquitinating Enzyme 14 or Ubiquitin Thioesterase 14 or Ubiquitin Specific Processing Protease 14 or USP14 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Marks & Spencer Group plc: Retailer Profile with IT Spending - Detailed positioning insight for Marks & Spencer Group plc to better understand your target

KOL Perspectives: JAK Inhibitor Safety in IBD

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023